Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016, Article ID 7496061, 10 pages
http://dx.doi.org/10.1155/2016/7496061
Research Article

Analyzing Dynamic Changes of Laboratory Indexes in Patients with Acute Heart Failure Based on Retrospective Study

1Core Laboratory of Translational Medicine, Chinese PLA General Hospital, Beijing 100853, China
2School of Medicine, Nankai University, Tianjin 300071, China
3Department of Medical Engineering, 401 Hospital of Chinese PLA, Qingdao 266071, China
4Computer Section of Chinese PLA General Hospital, Beijing 100853, China
5Department of Cardiology, Chinese PLA General Hospital, Beijing 100853, China

Received 5 January 2016; Revised 9 March 2016; Accepted 20 March 2016

Academic Editor: Laurent Metzinger

Copyright © 2016 Yurong Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Laribi, A. Aouba, M. Nikolaou et al., “Trends in death attributed to heart failure over the past two decades in Europe,” European Journal of Heart Failure, vol. 14, no. 3, pp. 234–239, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. J. J. McMurray, S. Adamopoulos, S. D. Anker et al., “ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC,” European Journal of Heart Failure, vol. 14, pp. 803–869, 2012. View at Google Scholar
  3. P. Jong, E. Vowinckel, P. P. Liu, Y. Gong, and J. V. Tu, “Prognosis and determinants of survival in patients newly hospitalized for heart failure: a population-based study,” Archives of Internal Medicine, vol. 162, no. 15, pp. 1689–1694, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. M. R. Cowie, K. F. Fox, D. A. Wood et al., “Hospitalization of patients with heart failure: a population-based study,” European Heart Journal, vol. 23, no. 11, pp. 877–885, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. J. L. Januzzi Jr. and R. Troughton, “Are serial BNP measurements useful in heart failure management? Serial natriuretic peptide measurements are useful in heart failure management,” Circulation, vol. 127, no. 4, pp. 500–508, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. G. Kwan, S. R. Isakson, J. Beede, P. Clopton, A. S. Maisel, and R. L. Fitzgerald, “Short-term serial sampling of natriuretic peptides in patients presenting with chest pain,” Journal of the American College of Cardiology, vol. 49, no. 11, pp. 1186–1192, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. B. Lindahl, J. Lindbäck, T. Jernberg et al., “Serial analyses of N-terminal pro-B-type natriuretic peptide in patients with non-ST-segment elevation acute coronary syndromes: a Fragmin and fast Revascularisation during InStability in Coronary artery disease (FRISC)-II substudy,” Journal of the American College of Cardiology, vol. 45, no. 4, pp. 533–541, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Masson, R. Latini, I. S. Anand et al., “Prognostic value of changes in N-terminal pro-brain natriuretic peptide in Val-HeFT (Valsartan Heart Failure Trial),” Journal of the American College of Cardiology, vol. 52, no. 12, pp. 997–1003, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Gheorghiade and P. S. Pang, “Acute heart failure syndromes,” Journal of the American College of Cardiology, vol. 53, no. 7, pp. 557–573, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Metra, G. Cotter, M. Gheorghiade, L. Dei Cas, and A. A. Voors, “The role of the kidney in heart failure,” European Heart Journal, vol. 33, no. 17, pp. 2135–2142, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Metra, G. Cotter, B. A. Davison et al., “Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the relaxin in acute heart failure (RELAX-AHF) development program: correlation with outcomes,” Journal of the American College of Cardiology, vol. 61, no. 2, pp. 196–206, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Bian, F. Xu, R.-J. Lv et al., “An early warning scoring system for the prevention of acute heart failure,” International Journal of Cardiology, vol. 183, pp. 111–116, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Thygesen, J. S. Alpert, A. S. Jaffe et al., “Third universal definition of myocardial infarction,” Circulation, vol. 126, pp. 2020–2035, 2012. View at Google Scholar
  14. Y.-C. Ma, L. Zuo, J.-H. Chen et al., “Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease,” Journal of the American Society of Nephrology, vol. 17, no. 10, pp. 2937–2944, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Link and M. Böhm, “New options in the treatment of acute heart failure,” Internist, vol. 55, no. 6, pp. 655–662, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. J. J. Park, D.-J. Choi, C.-H. Yoon et al., “The prognostic value of arterial blood gas analysis in high-risk acute heart failure patients: an analysis of the Korean Heart Failure (KorHF) registry,” European Journal of Heart Failure, vol. 17, no. 6, pp. 601–611, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. J. L. Januzzi, R. Van Kimmenade, J. Lainchbury et al., “NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: The international collaborative of NT-proBNP study,” European Heart Journal, vol. 27, no. 3, pp. 330–337, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Metra, S. Nodari, G. Parrinello et al., “Serial changes and independent prognostic value of NT-proBNP and cardiac troponin-T,” European Journal of Heart Failure, vol. 9, pp. 776–786, 2007. View at Google Scholar
  19. D. Logeart, G. Thabut, P. Jourdain et al., “Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure,” Journal of the American College of Cardiology, vol. 43, no. 4, pp. 635–641, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. J. L. Januzzi, G. Filippatos, M. Nieminen, and M. Gheorghiade, “Troponin elevation in patients with heart failure: on behalf of the third universal definition of myocardial infarction global task force: heart failure section,” European Heart Journal, vol. 33, no. 18, pp. 2265–2271, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. B. Metzler, A. Hammerer-Lercher, J. Jehle et al., “Plasma cardiac troponin T closely correlates with infarct size in a mouse model of acute myocardial infarction,” Clinica Chimica Acta, vol. 325, no. 1-2, pp. 87–90, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. R. D. Kociol, P. S. Pang, M. Gheorghiade, G. C. Fonarow, C. M. O'Connor, and G. M. Felker, “Troponin elevation in heart failure prevalence, mechanisms, and clinical implications,” Journal of the American College of Cardiology, vol. 56, no. 14, pp. 1071–1078, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Verma, S.-H. Li, M. V. Badiwala et al., “Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein,” Circulation, vol. 105, no. 16, pp. 1890–1896, 2002. View at Publisher · View at Google Scholar · View at Scopus
  24. H. Bahrami, D. A. Bluemke, R. Kronmal et al., “Novel metabolic risk factors for incident heart failure and their relationship with obesity: the MESA (Multi-Ethnic Study of Atherosclerosis) study,” Journal of the American College of Cardiology, vol. 51, no. 18, pp. 1775–1783, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. B. Devaux, D. Scholz, A. Hirche, W. P. Klovekorn, and J. Schaper, “Upregulation of cell adhesion molecules and the presence of low grade inflammation in human chronic heart failure,” European Heart Journal, vol. 18, no. 3, pp. 470–479, 1997. View at Publisher · View at Google Scholar · View at Scopus
  26. R. Jarai, C. Kaun, T. W. Weiss et al., “Human cardiac fibroblasts express B-type natriuretic peptide: fluvastatin ameliorates its up-regulation by interleukin-1α, tumour necrosis factor-α and transforming growth factor-β,” Journal of Cellular and Molecular Medicine, vol. 13, no. 11-12, pp. 4415–4421, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Thielmann, H. Dörge, C. Martin et al., “Myocardial dysfunction with coronary microembolization: signal transduction through a sequence of nitric oxide, tumor necrosis factor-α, and sphingosine,” Circulation Research, vol. 90, no. 7, pp. 807–813, 2002. View at Publisher · View at Google Scholar · View at Scopus
  28. M. H. Strauss and A. S. Hall, “Angiotensin receptor blockers may increase risk of myocardial infarction unraveling the ARB-MI paradox,” Circulation, vol. 114, no. 8, pp. 838–854, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Bangalore, S. Kumar, J. Wetterslev, and F. H. Messerli, “Angiotensin receptor blockers and risk of myocardial infarction: meta-analyses and trial sequential analyses of 147 020 patients from randomised trials,” British Medical Journal, vol. 342, no. 7805, Article ID d2234, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. Y. J. Youn, B.-S. Yoo, J.-W. Lee et al., “Treatment performance measures affect clinical outcomes in patients with acute systolic heart failure: report from the Korean heart failure registry,” Circulation Journal, vol. 76, no. 5, pp. 1151–1158, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. N. Polat, A. Yildiz, M. Z. Bilik et al., “The importance of hematologic indices in the risk stratification of patients with acute decompensated systolic heart failure,” Turk Kardiyoloji Dernegi Arsivi, vol. 43, no. 2, pp. 157–165, 2015. View at Publisher · View at Google Scholar · View at Scopus
  32. K. W. Prins, J. M. Neill, J. O. Tyler, P. M. Eckman, and S. Duval, “Effects of Beta-blocker withdrawal in acute decompensated heart failure: a systematic review and meta-analysis,” JACC Heart Failure, vol. 3, no. 8, pp. 647–653, 2015. View at Publisher · View at Google Scholar · View at Scopus
  33. J. Franco, F. Formiga, D. Chivite et al., “New onset heart failure—clinical characteristics and short-term mortality. A RICA (Spanish registry of acute heart failure) study,” European Journal of Internal Medicine, vol. 26, no. 5, pp. 357–362, 2015. View at Publisher · View at Google Scholar · View at Scopus
  34. Z. Iakobishvili, E. Cohen, M. Garty et al., “Use of intravenous morphine for acute decompensated heart failure in patients with and without acute coronary syndromes,” Acute Cardiac Care, vol. 13, no. 2, pp. 76–80, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. P. E. Marik and M. Flemmer, “Narrative review: the management of acute decompensated heart failure,” Journal of Intensive Care Medicine, vol. 27, no. 6, pp. 343–353, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. F. J. Ruiz-Laiglesia and M. Camafort-Babkowski, “Vasoactive and inotropic drugs in acute heart failure,” Medicina Clinica, vol. 142, supplement 1, pp. 49–54, 2014. View at Publisher · View at Google Scholar · View at Scopus